🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Despite the physiologic and clinical effects provided by coupling nebulizat...
Status
Completed
Location
Valdecir Castor Galindo Filho
Start Date
2007-06
Trial ID
NCT01012050
The purpose of this study was to assess whether the risk of serious asthma-...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2013-05
Trial ID
NCT01845025
Asthma is characterized by recurrent episodes of bronchospasm, bronchial hy...
Status
Completed
Location
Maisi David Cabral
Start Date
2015-01
Trial ID
NCT02939625
Treatments Being Tested
The purpose of this study is to determine whether using non-invasive measur...
Status
Completed
Location
Royal Brompton Hospital
Start Date
2005-12
Trial ID
NCT00262340
Treatments Being Tested
The investigators hypothesize that school-based, direct supervision of dail...
Status
Completed
Location
The University of Arizona and the Tucson Unified School District
Start Date
2014-08
Trial ID
NCT01997463
Treatments Being Tested
This study aims to assess the concordance of international asthma guideline...
Status
Recruiting
Location
Portsmouth Hospitals University NHS Trust
Start Date
2024-02-27
Trial ID
NCT06286085
Treatments Being Tested
To evaluate airway inflammation in persons with asthma exposed to endotoxin...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT00005550
The PRE-AR project is a longitudinal observational study. The primary objec...
Status
Terminated
Location
Institute of Biomedicine and Molecular Immunology, IBIM
Start Date
2015-03
Trial ID
NCT02636933
Treatments Being Tested
The purpose of this study is to assess the long-term safety performance of ...
Status
Completed
Location
Aventis Pharmaceutical Inc.
Start Date
2002-02
Trial ID
NCT00045955
Treatments Being Tested
ELBRUS is a 12-month (52-week), multi-centre, prospective, non-comparative ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2024-09-10
Trial ID
NCT06566885